CRO Inspection Fall-Out: Semler's Clients Have To Repeat Studies
This article was originally published in The Pink Sheet Daily
Executive Summary
Data integrity spotlight expands beyond cGMP as FDA finds Semler manipulated study subject samples in bioequivalence studies conducted at its Bangalore facility.